CC
ABBV icon

Cognios Capital’s AbbVie ABBV Stock Holding History

Cognios Capital’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-14,814
Closed -$1.13M – 2
2020
Q1 		$1.13M Buy
+14,814
New +$1.26M 0.56% 88
2019
Q1 		– Sell
-12,052
Closed -$1.11M – 131
2018
Q4 		$1.11M Buy
+12,052
New +$1.06M 0.45% 106
2018
Q3 		– Sell
-2,373
Closed -$219K – 138
2018
Q2 		$219K Sell
2,373
-3
-0.1% -$293 0.08% 147
2018
Q1 		$224K Buy
2,376
+263
+12% +$28.9K 0.08% 151
2017
Q4 		$204K Sell
2,113
-1,444
-41% -$136K 0.08% 161
2017
Q3 		$316K Buy
3,557
+68
+2% +$5.18K 0.13% 124
2017
Q2 		$252K Buy
+3,489
New +$235K 0.09% 141

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Cognios Capital's ABBV Position: Q2 2020 in Review

Cognios Capital sold out of AbbVie (ABBV) in Q2 2020, closing a stake of 14,814 shares — an estimated $1.13M sold.

Cognios Capital first reported a position in ABBV in Q2 2017 and held it in 7 quarters. The position peaked at $1.13M in Q1 2020. 2,412 funds tracked by Wall St. Rank hold ABBV as of Q2 2020.

  • Cognios Capital reported no remaining AbbVie position as of Q2 2020 after selling out during the quarter.
  • Cognios Capital sold 14,814 AbbVie shares in Q2 2020, an estimated $1.13M.
  • Cognios Capital first reported a position in AbbVie in Q2 2017 and held it in 7 quarters.
  • Cognios Capital's AbbVie position peaked at $1.13M in Q1 2020.
  • 2,412 funds tracked by Wall St. Rank held AbbVie as of Q2 2020.

Based on Cognios Capital's 13F filing for Q2 2020.